Describes the methods fieldworkers should use to collect oral health information for the survey of 3 year olds in the academic year 2019 to 2020. The population group for study is 3 year old children attending nurseries and playgroups. The
The government’s response to the Health and Social Care Committee’s report. It details the government’s response to all 11 recommendations from the Drugs policy: medicinal cannabis: Sixteenth Report of Session 2017–19: Report, together with formal minutes relating to the report
This report was funded by Innovate UK, part of UK Research and Innovation, for a research project undertaken by the IIPP and UCL Institute for Sustainable Resources. It introduces a new theoretical framework for understanding the links between fiscal policy
This is a policy report on re-imagining health innovation to deliver public value. A thriving health innovation system is characterised by its ability to generate new health technologies that improve public health and ensure access to effective treatments for the
A thriving health innovation system is characterised by its ability to generate new health technologies that improve public health and ensure access to effective treatments for the people who need them (World Health Organization, 2018). However, the existing health innovation
Latest Chief Medical Officer’s report considers current and future UK engagement with global health. The report consists of 21 letters from global health leaders to the Chief Medical Officer and their rsponse, responding summary, recommendations and epilogue. The report publishes
The government published its Industrial Strategy in November 2017, setting out a long-term plan to create an economy that boosts productivity and earning power throughout the UK. Critically, every local economic area in England, along with the devolved administrations, is
The NHS must be an active participant with industry in delivering the shared objective of outstanding patient outcomes. In part that is because it is a monopoly purchaser but also because the NHS should be where innovative products are developed
This report includes analysis of the innovation and research needs at local level across all Academic Health Science Networks. There were some differences in regional priorities but common themes emerged which reflected wider challenges facing the NHS and align with
This guide explains how to involve patients and carers in Quality Improvement (QI) projects. The toolkit covers topics such as: How to pay service users and carers How to recruit service users and carers How to run effective and inclusive meetings
This study presents a review of international evidence on best practice in organisational design of research and innovation funding bodies.
This report summarise research evaluating the main legal barriers to the better use of health data for pharmaceutical innovation. Issues are evaluated according to barriers arising in utilising data to support key activities across the lifecycle of a medicine: epidemiology
Report that looks at how to best harness advances in science to bring innovative drugs to patients. It is designed to help us reshape the landscape for drug discovery and development – and create tomorrow’s cancer treatments.
Research organisations: commitments to tackle sexual exploitation and abuse and sexual harassment in the international aid sector.
Research into patents and connected patent families using keywords relevant to point-of-care (POC) diagnostic tests for addressing antimicrobial resistance. This research analysed what patents are being filed and therefore what technology is being developed. The report assesses the implications on
Why should researchers, innovators and those whose jobs it is to regulate technology engage with people who aren’t like them on topics like research and innovation? To give those in power a broader range of potential futures to aspire to
Brief that aims to inform discussions about stimulating more meaningful productivity in terms of pharmaceutical R&D. More specifically, it explores how R&D efforts can be steered to areas of unmet clinical needs and how efficiency in the R&D process can
Selective non-publication of the results of research distorts the published evidence base and is a threat to research integrity. In the case of clinical trials, non-publication of results means that information on the efficacy of new drugs or other medical
The National Directive on Commercial Contract Research Studies sets out the requirements providers will need to adhere to for commercial contract research.